Recombinant Product Development
The team develops and characterizes new recombinant proteins, such as in the development of monoclonal antibodies for the treatment of inflammatory diseases, hereditary angioedema or lipid metabolism disorders.
The team develops and characterizes new recombinant proteins, such as in the development of monoclonal antibodies for the treatment of inflammatory diseases, hereditary angioedema or lipid metabolism disorders.